Accordingly, immunohistochemical examination revealed lost expression of PTEN in tumor cells as well as strong staining for phosphorylated Akt (Fig. 1A), which is consistent with a pathological activation of the pathway. The gene discussed is AKT1; the disease is neoplasm.